Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Finn

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Circulation|September 1, 2006
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomasScott D Solomon, Marc A Pfeffer, John J V McMurray, et al.
JACC. Heart Failure|April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMuthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
European Journal of Heart Failure|October 26, 2017
Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fractionNavkaranbir S Bajaj, Brian Claggett, Eldrin F Lewis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
Transplantation|February 25, 2016
B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant RecipientsPetr Jarolim, Brian L Claggett, Michael J Conrad, et al.
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Circulation|September 1, 2006
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomasScott D Solomon, Marc A Pfeffer, John J V McMurray, et al.
JACC. Heart Failure|April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMuthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
European Journal of Heart Failure|October 26, 2017
Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fractionNavkaranbir S Bajaj, Brian Claggett, Eldrin F Lewis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2015
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)David M Charytan, Eldrin F Lewis, Akshay S Desai, et al.
Transplantation|February 25, 2016
B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant RecipientsPetr Jarolim, Brian L Claggett, Michael J Conrad, et al.
JAMA Cardiology|October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVERAkshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 4